A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial. The trial results prompted a U.S. Food and Drug Administration (FDA) accelerated approval of the treatment on April 13, giving patients with this very aggressive type of cancer a new therapeutic option.
source https://www.sciencedaily.com/releases/2021/08/210802160627.htm
Tuesday, 3 August 2021
Related Posts
Whooping cranes steer clear of wind turbines when selecting stopover sites
Glaciers and enigmatic stone stripes in the Ethiopian highlands
Scientists sketch aged star system using over a century of observations
Birds learn to avoid flashy, hard-to-catch butterflies and their lookalikes
An unusual creature is coming out of winter's slumber: Here's why scientists are excited
Traces of Earth's early magma ocean identified in Greenland rocks
0 comments: